BioAdaptives(BDPT)
$0.000.00 (0.00%)
BDPT
BioAdaptives financials statements
$0.00
At close:0.00 (0.00%)
BioAdaptives (BDPT) Financial Statements
25 Followers
BioAdaptives Financial Overview
BioAdaptives's market cap is currently $236.31K. The company's EPS TTM is $-0.11; its P/E ratio is -0.01; BioAdaptives has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 18.28K | $ 12.67K | $ 28.57K | $ 17.18K | $ 19.78K |
| Gross Profit | $ 12.50K | $ 4.03K | $ 10.82K | $ 7.13K | $ 10.11K |
| Operating Income | $ -1.04M | $ -602.00K | $ -229.00K | $ -422.00K | $ -636.00K |
| EBITDA | $ -1.48M | $ -582.15K | $ -521.00K | $ -544.00K | $ -644.00K |
| Net Income | $ -1.56M | $ -899.00K | $ -712.00K | $ -896.00K | $ -1.05M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 158.44K | $ 137.47K | $ 60.78K | $ 25.45K | $ 83.13K |
| Total Assets | $ 225.90K | $ 261.88K | $ 104.00K | $ 37.31K | $ 148.59K |
| Total Debt | $ 384.43K | $ 343.10K | $ 329.18K | $ 392.04K | $ 436.83K |
| Net Debt | $ 225.98K | $ 205.63K | $ 268.40K | $ 366.63K | $ 353.90K |
| Total Liabilities | $ 2.36M | $ 1.73M | $ 1.75M | $ 1.49M | $ 1.24M |
| Stockholders' Equity | $ -2.13M | $ -1.46M | $ -1.65M | $ -1.45M | $ -1.09M |
| Cash Flow | |||||
| Free Cash Flow | $ -534.02K | $ -249.52K | $ -223.77K | $ -227.26K | $ -158.65K |
| Operating Cash Flow | $ -516.02K | $ -249.52K | $ -223.77K | $ -227.26K | $ -158.65K |
| Investing Cash Flow | $ -18.00K | $ 0.00 | $ 0.00 | $ 148.00 | $ 254.00 |
| Financing Cash Flow | $ 555.00K | $ 326.21K | $ 259.14K | $ 169.73K | $ 237.00K |
Currency in USD
